Helping people experiencing homelessness in New York City reduce overdose risk
CE24-013 - Community-based evaluation of a novel, system-wide harm reduction strategic plan for people experiencing homelessness in New York City
This project looks at how a new program in New York City shelters helps people experiencing homelessness stay safe from drug overdose.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11170374 on NIH RePORTER |
What this research studies
Many people experiencing homelessness face a high risk of drug overdose, which is a serious concern. This project is looking at a new program in New York City shelters designed to help people reduce their risk of overdose. The program offers harm reduction education to everyone entering a shelter and provides additional support and treatment services to those who need them. We want to understand how well this program works to keep people safe and healthy.
Who could benefit from this research
Good fit: This work is relevant to people experiencing homelessness in New York City who may be at risk of drug overdose.
Not a fit: Patients not experiencing homelessness or not residing in New York City shelters would not directly benefit from this specific program.
Why it matters
Potential benefit: If successful, this program could significantly reduce overdose deaths and improve the well-being of people experiencing homelessness in New York City.
How similar studies have performed: This is the first large-scale program of its kind in a major homeless services system, so its effectiveness is being carefully observed.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Allen, Bennett — New York University School of Medicine
- Study coordinator: Allen, Bennett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.